Neuropilin-1 Is a Direct Target of the Transcription Factor E2F1 during Cerebral Ischemia-Induced Neuronal Death In Vivo

REFERENCES

• Barrett, T., C. Cheadle, W. B. Wood, D. Teichberg, D. M. Donovan, W. J. Freed, K. G. Becker, and M. P. Vawter. 2001. Assembly and use of a broadly applicable neural cDNA microarray. Restor. Neurol. Neurosci. 18:127–135.
   PubMed Web of Science ®Google Scholar
• Beck, H., T. Acker, A. W. Puschel, H. Fujisawa, P. Carmeliet, and K. H. Plate. 2002. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J. Neuropathol. Exp. Neurol. 61:339–350.
   PubMedGoogle Scholar
• Carmichael, S. T. 2006. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann. Neurol. 59:735–742.
   PubMed Web of Science ®Google Scholar
• Carmichael, S. T., I. Archibeque, L. Luke, T. Nolan, J. Momiy, and S. Li. 2005. Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp. Neurol. 193:291–311.
   PubMed Web of Science ®Google Scholar
• Castellani, V. 2002. The function of neuropilin/L1 complex. Adv. Exp. Med. Biol. 515:91–102.
   PubMed Web of Science ®Google Scholar
• Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392–2404.
   PubMed Web of Science ®Google Scholar
• De Winter, F., A. J. Holtmaat, and J. Verhaagen. 2002. Neuropilin and class 3 semaphorins in nervous system regeneration. Adv. Exp. Med. Biol. 515:115–139.
   PubMedGoogle Scholar
• Dimova, D. K., and N. J. Dyson. 2005. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24:2810–2826.
   PubMed Web of Science ®Google Scholar
• Fujisawa, H. 2002. From the discovery of neuropilin to the determination of its adhesion sites. Adv. Exp. Med. Biol. 515:1–12.
   PubMed Web of Science ®Google Scholar
• Fujita, H., B. Zhang, K. Sato, J. Tanaka, and M. Sakanaka. 2001. Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res. 914:1–14.
   PubMedGoogle Scholar
• Gendron, T. F., G. A. Mealing, J. Paris, A. Lou, A. Edwards, S. T. Hou, J. P. MacManus, A. M. Hakim, and P. Morley. 2001. Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F1 knockout mice. J. Neurochem. 78:316–324.
   PubMedGoogle Scholar
• Giger, R. J., J. F. Cloutier, A. Sahay, R. K. Prinjha, D. V. Levengood, S. E. Moore, S. Pickering, D. Simmons, S. Rastan, F. S. Walsh, A. L. Kolodkin, D. D. Ginty, and M. Geppert. 2000. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25:29–41.
   PubMed Web of Science ®Google Scholar
• Giger, R. J., R. J. Pasterkamp, A. J. Holtmaat, and J. Verhaagen. 1998. Semaphorin III: role in neuronal development and structural plasticity. Prog. Brain Res. 117:133–149.
   PubMedGoogle Scholar
• Giovanni, A., E. Keramaris, E. J. Morris, S. T. Hou, M. O'Hare, N. Dyson, G. S. Robertson, R. S. Slack, and D. S. Park. 2000. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275:11553–11560.
   PubMed Web of Science ®Google Scholar
• Greene, L. A., S. C. Biswas, and D. X. Liu. 2004. Cell cycle molecules and vertebrate neuron death: E2F at the hub. Cell Death. Differ. 11:49–60.
   PubMedGoogle Scholar
• He, Z., and M. Tessier-Lavigne. 1997. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90:739–751.
   PubMed Web of Science ®Google Scholar
• Hou, S. T., K. G. Becker, A. Baggley, G. Chen, and J. Webster. 2003. High-density DNA microarray analysis of gene expression following transient focal cerebral ischemia in mouse. Int. Congr. Ser. 1252:45–56.
   Google Scholar
• Hou, S. T., D. Callaghan, M. C. Fournier, I. Hill, L. Kang, B. Massie, P. Morley, C. Murray, I. Rasquinha, R. Slack, and J. P. MacManus. 2000. The transcription factor E2F1 modulates apoptosis of neurons. J. Neurochem. 75:91–100.
   PubMedGoogle Scholar
• Hou, S. T., E. Cowan, S. Dostanic, I. Rasquinha, T. Comas, P. Morley, and J. P. MacManus. 2001. Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons. Neurosci. Lett. 306:153–156.
   PubMed Web of Science ®Google Scholar
• Hou, S. T., E. Cowan, T. Walker, N. Ohan, M. Dove, I. Rasqinha, and J. P. MacManus. 2001. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J. Neurochem. 78:287–297.
   PubMedGoogle Scholar
• Hou, S. T., S. X. Jiang, A. Desbois, D. Huang, J. Kelly, L. Tessier, L. Karchewski, and J. Kappler. 2006. Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J. Neurosci. 26:2241–2249.
   PubMedGoogle Scholar
• Hou, S. T., and J. P. MacManus. 2002. Molecular mechanisms of cerebral ischemia-induced neuronal death. Int. Rev. Cytol. 221:93–148.
   PubMedGoogle Scholar
• Hou, S. T., Y. Tu, A. M. Buchan, Z. Huang, E. Preston, I. Rasquinha, G. S. Robertson, and J. P. MacManus. 1997. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia. Biochem. Cell Biol. 75:383–392.
   PubMed Web of Science ®Google Scholar
• Hou, S. T., X. Xie, A. Baggley, D. S. Park, G. Chen, and T. Walker. 2002. Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis. J. Biol. Chem. 277:48764–48770.
   PubMedGoogle Scholar
• Iglesias, A. H., S. Camelo, D. Hwang, R. Villanueva, G. Stephanopoulos, and F. Dangond. 2004. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells. J. Neuroimmunol. 150:163–177.
   PubMed Web of Science ®Google Scholar
• Kawasaki, T., Y. Bekku, F. Suto, T. Kitsukawa, M. Taniguchi, I. Nagatsu, T. Nagatsu, K. Itoh, T. Yagi, and H. Fujisawa. 2002. Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system. Development 129:671–680.
   PubMed Web of Science ®Google Scholar
• Keyvani, K., O. W. Witte, and W. Paulus. 2002. Gene expression profiling in perilesional and contralateral areas after ischemia in rat brain. J. Cereb. Blood Flow Metab. 22:153–160.
   PubMedGoogle Scholar
• Kitsukawa, T., M. Shimizu, M. Sanbo, T. Hirata, M. Taniguchi, Y. Bekku, T. Yagi, and H. Fujisawa. 1997. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19:995–1005.
   PubMed Web of Science ®Google Scholar
• Kitsukawa, T., A. Shimono, A. Kawakami, H. Kondoh, and H. Fujisawa. 1995. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121:4309–4318.
   PubMed Web of Science ®Google Scholar
• Kolodkin, A. L., D. V. Levengood, E. G. Rowe, Y. T. Tai, R. J. Giger, and D. D. Ginty. 1997. Neuropilin is a semaphorin III receptor. Cell 90:753–762.
   PubMed Web of Science ®Google Scholar
• Liu, D. X., and L. A. Greene. 2001. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32:425–438.
   PubMedGoogle Scholar
• MacManus, J. P., M. Jian, E. Preston, I. Rasquinha, J. Webster, and B. Zurakowski. 2003. Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice. J. Cereb. Blood Flow Metab. 23:1020–1028.
   PubMedGoogle Scholar
• MacManus, J. P., C. J. Koch, M. Jian, T. Walker, and B. Zurakowski. 1999. Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1. Neuroreport 10:2711–2714.
   PubMedGoogle Scholar
• MacManus, J. P., I. Rasquinha, M. A. Black, N. B. Laferriere, R. Monette, T. Walker, and P. Morley. 1997. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp. Cell Res. 233:310–320.
   PubMed Web of Science ®Google Scholar
• O'Hare, M. J., S. T. Hou, E. J. Morris, S. P. Cregan, Q. Xu, R. S. Slack, and D. S. Park. 2000. Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275:25358–25364.
   PubMed Web of Science ®Google Scholar
• Pasterkamp, R. J., F. De Winter, A. J. Holtmaat, and J. Verhaagen. 1998. Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J. Neurosci. 18:9962–9976.
   PubMedGoogle Scholar
• Pasterkamp, R. J., and A. L. Kolodkin. 2003. Semaphorin junction: making tracks toward neural connectivity. Curr. Opin. Neurobiol. 13:79–89.
   PubMed Web of Science ®Google Scholar
• Puschel, A. W. 2002. The function of neuropilin/plexin complexes. Adv. Exp. Med. Biol. 515:71–80.
   PubMedGoogle Scholar
• Ren, B., H. Cam, Y. Takahashi, T. Volkert, J. Terragni, R. A. Young, and B. D. Dynlacht. 2002. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16:245–256.
   PubMed Web of Science ®Google Scholar
• Rossignol, M., J. Pouyssegur, and M. Klagsbrun. 2003. Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1. J. Cell Biochem. 88:744–757.
   PubMedGoogle Scholar
• Saunders, P. A., R. W. Chen, and D. M. Chuang. 1999. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J. Neurochem. 72:925–932.
   PubMed Web of Science ®Google Scholar
• Shirvan, A., M. Kimron, V. Holdengreber, I. Ziv, Y. Ben Shaul, S. Melamed, E. Melamed, A. Barzilai, and A. S. Solomon. 2002. Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J. Biol. Chem. 277:49799–49807.
   PubMed Web of Science ®Google Scholar
• Shirvan, A., I. Ziv, G. Fleminger, R. Shina, Z. He, I. Brudo, E. Melamed, and A. Barzilai. 1999. Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 73:961–971.
   PubMed Web of Science ®Google Scholar
• Smith, R. A., T. Walker, X. Xie, and S. T. Hou. 2003. Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Mol. Brain Res. 116:70–79.
   PubMedGoogle Scholar
• Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11–20.
   PubMed Web of Science ®Google Scholar
• Wang, F., M. J. O'Hare, and D. S. Park. 2001. Cyclin-dependent kinases and stroke. Exp. Opin. Ther. Targets 5:557–567.
   PubMedGoogle Scholar
• Wang, S., N. Nath, A. Minden, and S. Chellappan. 1999. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 18:1559–1570.
   PubMedGoogle Scholar
• Weinmann, A. S., S. M. Bartley, T. Zhang, M. Q. Zhang, and P. J. Farnham. 2001. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21:6820–6832.
   PubMed Web of Science ®Google Scholar
• Wells, J., C. R. Graveel, S. M. Bartley, S. J. Madore, and P. J. Farnham. 2002. The identification of E2F1-specific target genes. Proc. Natl. Acad. Sci. USA 99:3890–3895.
   PubMedGoogle Scholar
• Williams, G., B. J. Eickholt, P. Maison, R. Prinjha, F. S. Walsh, and P. Doherty. 2005. A complementary peptide approach applied to the design of novel semaphorin/neuropilin antagonists. J. Neurochem. 92:1180–1190.
   PubMedGoogle Scholar
• Wong, C. F., A. Guminski, N. A. Saunders, and A. J. Burgess. 2005. Exploiting novel cell cycle targets in the development of anticancer agents. Curr. Cancer Drug Targets. 5:85–102.
   PubMedGoogle Scholar
• Zhang, Z. G., W. Tsang, L. Zhang, C. Powers, and M. Chopp. 2001. Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J. Cereb. Blood Flow Metab. 21:541–549.
   PubMed Web of Science ®Google Scholar